BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260512T185422EDT-46013f3ix1@132.216.98.100
DTSTAMP:20260512T225422Z
DESCRIPTION:Dr. Florian Marx is a physician and epidemiologist at Heidelber
 g University Hospital\, Germany. His research focuses on the epidemiology 
 of tuberculosis (TB) and the impact of public health interventions on redu
 cing TB morbidity and mortality in high-risk populations. He currently lea
 ds an Emmy Noether Research Group funded by the German Research Foundation
  focused on strategies to optimize TB treatment outcomes. His other projec
 ts include modelling to estimate the population-level impact of the Gates 
 Foundation R&D portfolio for TB and health-economic evaluations of novel T
 B diagnostics. His group also contributes to the global TB screening inves
 tment case initiated by the WHO.\n\nTitle: Optimizing tuberculosis treatme
 nt outcomes beyond new drugs: a causal modelling framework for real-world 
 impact\n\nSummary: This talk will address the persistent gap between tuber
 culosis (TB) treatment outcomes among participants of drug trials and indi
 viduals receiving routine TB care. It will introduce OpTBtreat\, a six-yea
 r fellowship project funded by the German Research Foundation that aims to
  generate new insights into key drivers and mechanisms of poor treatment o
 utcomes\, and to integrate this knowledge into a modelling and health-econ
 omic framework to enable prioritization and systematic assessment of tools
  and strategies. The talk will highlight early progress and discuss how th
 is work can inform more effective\, individualized\, and scalable interven
 tions to improve health outcomes among TB patients globally.\n\nYou can jo
 in the session virtually using this link or meeting ID: 825 5213 8895 with
  passcode: TBFacts\n
DTSTART:20260515T160000Z
DTEND:20260515T170000Z
SUMMARY:TB Seminar –Dr. Florian Marx
URL:/sociology/channels/event/tb-seminar-dr-florian-ma
 rx-372845
END:VEVENT
END:VCALENDAR